1. Home
  2. ETNB vs HUYA Comparison

ETNB vs HUYA Comparison

Compare ETNB & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • HUYA
  • Stock Information
  • Founded
  • ETNB 2018
  • HUYA 2014
  • Country
  • ETNB United States
  • HUYA China
  • Employees
  • ETNB N/A
  • HUYA N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • HUYA Computer Software: Programming Data Processing
  • Sector
  • ETNB Health Care
  • HUYA Technology
  • Exchange
  • ETNB Nasdaq
  • HUYA Nasdaq
  • Market Cap
  • ETNB 1.2B
  • HUYA 1.0B
  • IPO Year
  • ETNB 2019
  • HUYA 2018
  • Fundamental
  • Price
  • ETNB $7.34
  • HUYA $3.21
  • Analyst Decision
  • ETNB Strong Buy
  • HUYA Buy
  • Analyst Count
  • ETNB 10
  • HUYA 4
  • Target Price
  • ETNB $27.56
  • HUYA $5.68
  • AVG Volume (30 Days)
  • ETNB 2.1M
  • HUYA 3.5M
  • Earning Date
  • ETNB 05-08-2025
  • HUYA 03-18-2025
  • Dividend Yield
  • ETNB N/A
  • HUYA 78.19%
  • EPS Growth
  • ETNB N/A
  • HUYA N/A
  • EPS
  • ETNB N/A
  • HUYA N/A
  • Revenue
  • ETNB N/A
  • HUYA $832,858,160.00
  • Revenue This Year
  • ETNB N/A
  • HUYA $8.88
  • Revenue Next Year
  • ETNB N/A
  • HUYA $5.62
  • P/E Ratio
  • ETNB N/A
  • HUYA N/A
  • Revenue Growth
  • ETNB N/A
  • HUYA N/A
  • 52 Week Low
  • ETNB $5.99
  • HUYA $2.82
  • 52 Week High
  • ETNB $11.84
  • HUYA $6.84
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 39.62
  • HUYA 38.49
  • Support Level
  • ETNB $7.66
  • HUYA $3.23
  • Resistance Level
  • ETNB $9.32
  • HUYA $3.45
  • Average True Range (ATR)
  • ETNB 0.77
  • HUYA 0.24
  • MACD
  • ETNB -0.04
  • HUYA -0.08
  • Stochastic Oscillator
  • ETNB 9.04
  • HUYA 4.17

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About HUYA HUYA Inc. American depositary shares each representing one ordinary share

Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2023, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.

Share on Social Networks: